95 related articles for article (PubMed ID: 38720389)
1. Molecular Markers in Melanoma Progression: A Study on the Expression of miRNA Gene Subtypes in Tumoral vs. Benign Nevi.
Prodan M; Costescu S; Elagez A; Laitin SMD; Bloanca V; Crainiceanu Z; Seclaman E; Toma AO; Fericean RM; Puenea G; Cozma GV
Curr Oncol; 2024 May; 31(5):2881-2894. PubMed ID: 38785501
[TBL] [Abstract][Full Text] [Related]
2. Discovery of PELATON links to the INHBA gene in the TGF-β pathway in colorectal cancer using a combination of bioinformatics and experimental investigations.
Abutalebi M; Li D; Ahmad W; Mokhtari K; Entezari M; Hashemi M; Fu J; Maghsoudloo M
Int J Biol Macromol; 2024 Jun; 270(Pt 1):132239. PubMed ID: 38735606
[TBL] [Abstract][Full Text] [Related]
3. Novel RNA molecular bioengineering technology efficiently produces functional miRNA agents.
Traber GM; Yi C; Batra N; Tu MJ; Yu AM
RNA; 2024 May; 30(6):680-694. PubMed ID: 38429100
[TBL] [Abstract][Full Text] [Related]
4. Regulatory effects of microRNAs on monocytic HLA-DR surface expression.
Folini A; Zhang L; Luedi MM; Moolan-Vadackumchery R; Matthiss L; Hoffmann A; Stüber F; Huang MY
Eur J Immunol; 2024 May; ():e2350756. PubMed ID: 38778505
[TBL] [Abstract][Full Text] [Related]
5. Are miR-26a and miR-26b microRNAs potent prognostic markers of gestational diabetes?
Ghaneialvar H; Mohseni MM; Kenarkoohi A; Kakaee S
Health Sci Rep; 2024 Jun; 7(6):e2152. PubMed ID: 38831779
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-26b suppresses autophagy in breast cancer cells by targeting DRAM1 mRNA, and is downregulated by irradiation.
Meng C; Liu Y; Shen Y; Liu S; Wang Z; Ye Q; Liu H; Liu X; Jia L
Oncol Lett; 2018 Feb; 15(2):1435-1440. PubMed ID: 29399189
[TBL] [Abstract][Full Text] [Related]
7. G-Protein Signaling Modulator 2 as a Potential Biomarker in Colorectal Cancer: Integrative Analysis Using Genetic Profiling and Pan-Cancer Studies.
Kadhim DJ; Azari H; Sokhangouy SK; Hassanian SM; Alshekarchi HI; Goshayeshi L; Goshayeshi L; Abbaszadegan MR; Khojasteh-Leylakoohi F; Khazaei M; Gataa IS; Peters GJ; A Ferns G; Batra J; Lam AK; Giovannetti E; Avan A
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674408
[TBL] [Abstract][Full Text] [Related]
8. Interplay of miR-542, miR-126, miR-143 and miR-26b with PI3K-Akt is a Diagnostic Signal and Putative Regulatory Target in HPV-Positive Cervical Cancer.
Rahimi-Moghaddam A; Ghorbanmehr N; Gharbi S; Nili F; Korsching E
Biochem Genet; 2024 Jun; ():. PubMed ID: 38849709
[TBL] [Abstract][Full Text] [Related]
9. LNA-i-miR-221 activity in colorectal cancer: A reverse translational investigation.
Ali A; Grillone K; Ascrizzi S; Caridà G; Fiorillo L; Ciliberto D; Staropoli N; Tagliaferri P; Tassone P; Di Martino MT
Mol Ther Nucleic Acids; 2024 Jun; 35(2):102221. PubMed ID: 38868363
[TBL] [Abstract][Full Text] [Related]
10. IL-2RG as a possible immunotherapeutic target in CRC predicting poor prognosis and regulated by miR-7-5p and miR-26b-5p.
Gharib E; Rejali L; Piroozkhah M; Zonoobi E; Nasrabadi PN; Arabsorkhi Z; Baghdar K; Shams E; Sadeghi A; Kuppen PJK; Salehi Z; Nazemalhosseini-Mojarad E
J Transl Med; 2024 May; 22(1):439. PubMed ID: 38720389
[TBL] [Abstract][Full Text] [Related]
11. The molecular mechanism of actions and clinical utilities of tumor infiltrating lymphocytes in gastrointestinal cancers: a comprehensive review and future prospects toward personalized medicine.
Piroozkhah M; Gholinezhad Y; Piroozkhah M; Shams E; Nazemalhosseini-Mojarad E
Front Immunol; 2023; 14():1298891. PubMed ID: 38077386
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous targeting of PD-1 and IL-2Rβγ with radiation therapy inhibits pancreatic cancer growth and metastasis.
Piper M; Hoen M; Darragh LB; Knitz MW; Nguyen D; Gadwa J; Durini G; Karakoc I; Grier A; Neupert B; Van Court B; Abdelazeem KNM; Yu J; Olimpo NA; Corbo S; Ross RB; Pham TT; Joshi M; Kedl RM; Saviola AJ; Amann M; Umaña P; Codarri Deak L; Klein C; D'Alessandro A; Karam SD
Cancer Cell; 2023 May; 41(5):950-969.e6. PubMed ID: 37116489
[TBL] [Abstract][Full Text] [Related]
13. The ceRNA network regulates epithelial-mesenchymal transition in colorectal cancer.
Li R; Xu H; Gao X
Heliyon; 2023 Mar; 9(3):e14143. PubMed ID: 36950593
[TBL] [Abstract][Full Text] [Related]
14. The application of Interleukin-2 family cytokines in tumor immunotherapy research.
Zhou Y; Quan G; Liu Y; Shi N; Wu Y; Zhang R; Gao X; Luo L
Front Immunol; 2023; 14():1090311. PubMed ID: 36936961
[TBL] [Abstract][Full Text] [Related]
15. LncTarD 2.0: an updated comprehensive database for experimentally-supported functional lncRNA-target regulations in human diseases.
Zhao H; Yin X; Xu H; Liu K; Liu W; Wang L; Zhang C; Bo L; Lan X; Lin S; Feng K; Ning S; Zhang Y; Wang L
Nucleic Acids Res; 2023 Jan; 51(D1):D199-D207. PubMed ID: 36321659
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA Regulatory Network Analysis Using miRNet 2.0.
Chang L; Xia J
Methods Mol Biol; 2023; 2594():185-204. PubMed ID: 36264497
[TBL] [Abstract][Full Text] [Related]
17. Mechanism and strategies of immunotherapy resistance in colorectal cancer.
Shan J; Han D; Shen C; Lei Q; Zhang Y
Front Immunol; 2022; 13():1016646. PubMed ID: 36238278
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of exosomal miR-7-5p promotes breast cancer migration and invasion by targeting RYK and participating in the atypical WNT signalling pathway.
Liang Z; Liu L; Gao R; Che C; Yang G
Cell Mol Biol Lett; 2022 Oct; 27(1):88. PubMed ID: 36210461
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
